Mutant p53 and ETS2, a tale of reciprocity
TP53 is one of the most frequently inactivated tumor suppressor genes in human cancer. However, unlike other tumor suppressor genes whose expression is lost, TP53 is usually inactivated as a result of a single nucleotide change within the coding region. Typically, these single nucleotide mutations...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2016-02-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00035/full |
id |
doaj-b71c2e5041fb4e65b367f04a53a64cf9 |
---|---|
record_format |
Article |
spelling |
doaj-b71c2e5041fb4e65b367f04a53a64cf92020-11-24T23:57:57ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2016-02-01610.3389/fonc.2016.00035180184Mutant p53 and ETS2, a tale of reciprocityLuis Alfonso Martinez0Stony Brook UniversityTP53 is one of the most frequently inactivated tumor suppressor genes in human cancer. However, unlike other tumor suppressor genes whose expression is lost, TP53 is usually inactivated as a result of a single nucleotide change within the coding region. Typically, these single nucleotide mutations result in a codon change that creates an amino acid substitution. Thus, unlike other tumor suppressor genes whose expression is lost due to genetic or epigenetic changes, the p53 gene primarily suffers missense mutations and therefore the cells retain and express a mutant form of the p53 protein (mtp53). It is now well established that mtp53 contributes to tumor development through its gain-of-function activities. These gain-of-function (GOF) activities can arise from novel protein-protein interactions that can either disable other tumor suppressors (e.g. p63, p73) or enable oncogenes such as ETS2, an ETS family member. In this review, I will focus on the identification of the mtp53/ETS2 complex and outline the diverse activities that this transcriptional regulatory complex controls to promote cancer.http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00035/fullTranscription FactorsTumor Suppressor Protein p53Cancerp53Ets2 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Luis Alfonso Martinez |
spellingShingle |
Luis Alfonso Martinez Mutant p53 and ETS2, a tale of reciprocity Frontiers in Oncology Transcription Factors Tumor Suppressor Protein p53 Cancer p53 Ets2 |
author_facet |
Luis Alfonso Martinez |
author_sort |
Luis Alfonso Martinez |
title |
Mutant p53 and ETS2, a tale of reciprocity |
title_short |
Mutant p53 and ETS2, a tale of reciprocity |
title_full |
Mutant p53 and ETS2, a tale of reciprocity |
title_fullStr |
Mutant p53 and ETS2, a tale of reciprocity |
title_full_unstemmed |
Mutant p53 and ETS2, a tale of reciprocity |
title_sort |
mutant p53 and ets2, a tale of reciprocity |
publisher |
Frontiers Media S.A. |
series |
Frontiers in Oncology |
issn |
2234-943X |
publishDate |
2016-02-01 |
description |
TP53 is one of the most frequently inactivated tumor suppressor genes in human cancer. However, unlike other tumor suppressor genes whose expression is lost, TP53 is usually inactivated as a result of a single nucleotide change within the coding region. Typically, these single nucleotide mutations result in a codon change that creates an amino acid substitution. Thus, unlike other tumor suppressor genes whose expression is lost due to genetic or epigenetic changes, the p53 gene primarily suffers missense mutations and therefore the cells retain and express a mutant form of the p53 protein (mtp53). It is now well established that mtp53 contributes to tumor development through its gain-of-function activities. These gain-of-function (GOF) activities can arise from novel protein-protein interactions that can either disable other tumor suppressors (e.g. p63, p73) or enable oncogenes such as ETS2, an ETS family member. In this review, I will focus on the identification of the mtp53/ETS2 complex and outline the diverse activities that this transcriptional regulatory complex controls to promote cancer. |
topic |
Transcription Factors Tumor Suppressor Protein p53 Cancer p53 Ets2 |
url |
http://journal.frontiersin.org/Journal/10.3389/fonc.2016.00035/full |
work_keys_str_mv |
AT luisalfonsomartinez mutantp53andets2ataleofreciprocity |
_version_ |
1725452552141537280 |